Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded indication for the OmniaSecure™ defibrillation lead. Now ...

Medtronic (NYSE: MDT) announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.

Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc ...

The cases highlight the effectiveness of rapid coordination between frontline healthcare facilities and specialised hospitals ...

OmniaSecure is now the first defibrillation lead approved for placement in the left bundle branch.

Short for atrial fibrillation, A-fib is a quivering or irregular heartbeat that is a worrisome stage-setter for blood clots, ...

A 173-patient randomized trial in HFrEF (LVEF ≤35%) with LBBB (QRS ≥130 ms) showed CSP was inferior to BiVP for a hierarchical 12‑month composite endpoint. Worse outcomes with CSP were reflected by an ...

Electrical signals tell the heart to contract, but when the signals form spiral waves, they can lead to dangerous cardiac events like tachycardia and fibrillation. Researchers are bringing a new ...

Turco, an interventional cardiologist, has held roles including CEO of JC Medical and chief medical officer of Medtronic’s ...

A liquid injected into the heart that sets like a gel could one day prevent strokes caused by atrial fibrillation, animal tests suggest.

Bronson Methodist is the first facility in southwest Michigan to offer the VARIPULSE™ Pulsed Field Ablation Platform for ...